Cargando…

Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides

BACKGROUND AND PURPOSE: A lower proportion of CD8+ tumor infiltrating lymphocytes in mycosis fungoides (MF) patients is associated with worse survival. However, it is not known whether circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam therapy (TSEBT). METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yi, Jiang, Wen, Andraos, Therese Y., Reddy, Jay P., Yehia, Zeinab Abou, Lloyd, Shane, Duvic, Madeleine, D’Souza, Neil M., Milgrom, Sarah A., Pinnix, Chelsea C., Oki, Yasuhiro, Smith, Grace L., Wilson, Lynn D., Dabaja, Bouthaina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662194/
https://www.ncbi.nlm.nih.gov/pubmed/30773193
http://dx.doi.org/10.1016/j.radonc.2018.12.003
_version_ 1783439609071403008
author An, Yi
Jiang, Wen
Andraos, Therese Y.
Reddy, Jay P.
Yehia, Zeinab Abou
Lloyd, Shane
Duvic, Madeleine
D’Souza, Neil M.
Milgrom, Sarah A.
Pinnix, Chelsea C.
Oki, Yasuhiro
Smith, Grace L.
Wilson, Lynn D.
Dabaja, Bouthaina S.
author_facet An, Yi
Jiang, Wen
Andraos, Therese Y.
Reddy, Jay P.
Yehia, Zeinab Abou
Lloyd, Shane
Duvic, Madeleine
D’Souza, Neil M.
Milgrom, Sarah A.
Pinnix, Chelsea C.
Oki, Yasuhiro
Smith, Grace L.
Wilson, Lynn D.
Dabaja, Bouthaina S.
author_sort An, Yi
collection PubMed
description BACKGROUND AND PURPOSE: A lower proportion of CD8+ tumor infiltrating lymphocytes in mycosis fungoides (MF) patients is associated with worse survival. However, it is not known whether circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam therapy (TSEBT). METHODS AND MATERIALS: We identified 126 MF patients treated with TSEBT from 2001 to 20014 at two high-volume academic centers. Circulating CD4:CD8 ratio was obtained within 1 week before TSEBT. TSEBT was delivered with 6–9mEV electrons with low (12 Gy) or conventional (≥12 Gy) doses. Treatment response was assessed with the modified Severity Weighted Assessment Tool (mSWAT). Post-treatment mSWAT decrease of ≥75% was classified as near complete response (CR) while mSWAT decrease of <75% was considered partial response (PR). Receiver operating characteristic analysis determined an optimal CD4:CD8 threshold value to predict TSEBT response in the derivation cohort and was applied to an external validation cohort. RESULTS: 71.4% and 28.6% of patients achieved CR and PR after TSEBT. Higher CD4:CD8 ratio predicted poorer response: median CD4:CD8 in patients with PR vs. CR was 4.84 vs. 1.97 (p = 0.002). A threshold CD4:CD8 of 4.42 optimally discriminated in the discovery cohort patients with PR vs. XR (sensitivity 90%, specificity 59%, area under curve (AUC) = 0.71; p = 0.002). Within an independent test cohort (n = 32), 73.9% of patients with CD4:CD8 <4.42 achieved CR vs. 33.3% of those with CD4:CD8 ≥4.42 (p = 0.033). Among all patients with CD4:CD8 <4.42 (n = 73), 74% achieved CR with low-dose TSEBT vs. 93% with conventional dose TSEBT (p = 0.02). On multivariable logistic regression, CD4:CD8 remained a significant independent predictor of TSEBT response in all patients (OR = 0.107, 95% CI 0.395–0.290, p < 0.001). CONCLUSION: Peripheral blood CD4:CD8 ratio was a significant independent predictor of TSEBT response of MF patients as validated in an independent cohort at separate academic center. The potential for CD4: CD8 ratio as a biomarker to inform radiation treatment dosing warrants further investigation.
format Online
Article
Text
id pubmed-6662194
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-66621942020-02-01 Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides An, Yi Jiang, Wen Andraos, Therese Y. Reddy, Jay P. Yehia, Zeinab Abou Lloyd, Shane Duvic, Madeleine D’Souza, Neil M. Milgrom, Sarah A. Pinnix, Chelsea C. Oki, Yasuhiro Smith, Grace L. Wilson, Lynn D. Dabaja, Bouthaina S. Radiother Oncol Article BACKGROUND AND PURPOSE: A lower proportion of CD8+ tumor infiltrating lymphocytes in mycosis fungoides (MF) patients is associated with worse survival. However, it is not known whether circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam therapy (TSEBT). METHODS AND MATERIALS: We identified 126 MF patients treated with TSEBT from 2001 to 20014 at two high-volume academic centers. Circulating CD4:CD8 ratio was obtained within 1 week before TSEBT. TSEBT was delivered with 6–9mEV electrons with low (12 Gy) or conventional (≥12 Gy) doses. Treatment response was assessed with the modified Severity Weighted Assessment Tool (mSWAT). Post-treatment mSWAT decrease of ≥75% was classified as near complete response (CR) while mSWAT decrease of <75% was considered partial response (PR). Receiver operating characteristic analysis determined an optimal CD4:CD8 threshold value to predict TSEBT response in the derivation cohort and was applied to an external validation cohort. RESULTS: 71.4% and 28.6% of patients achieved CR and PR after TSEBT. Higher CD4:CD8 ratio predicted poorer response: median CD4:CD8 in patients with PR vs. CR was 4.84 vs. 1.97 (p = 0.002). A threshold CD4:CD8 of 4.42 optimally discriminated in the discovery cohort patients with PR vs. XR (sensitivity 90%, specificity 59%, area under curve (AUC) = 0.71; p = 0.002). Within an independent test cohort (n = 32), 73.9% of patients with CD4:CD8 <4.42 achieved CR vs. 33.3% of those with CD4:CD8 ≥4.42 (p = 0.033). Among all patients with CD4:CD8 <4.42 (n = 73), 74% achieved CR with low-dose TSEBT vs. 93% with conventional dose TSEBT (p = 0.02). On multivariable logistic regression, CD4:CD8 remained a significant independent predictor of TSEBT response in all patients (OR = 0.107, 95% CI 0.395–0.290, p < 0.001). CONCLUSION: Peripheral blood CD4:CD8 ratio was a significant independent predictor of TSEBT response of MF patients as validated in an independent cohort at separate academic center. The potential for CD4: CD8 ratio as a biomarker to inform radiation treatment dosing warrants further investigation. 2018-12-31 2019-02 /pmc/articles/PMC6662194/ /pubmed/30773193 http://dx.doi.org/10.1016/j.radonc.2018.12.003 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
An, Yi
Jiang, Wen
Andraos, Therese Y.
Reddy, Jay P.
Yehia, Zeinab Abou
Lloyd, Shane
Duvic, Madeleine
D’Souza, Neil M.
Milgrom, Sarah A.
Pinnix, Chelsea C.
Oki, Yasuhiro
Smith, Grace L.
Wilson, Lynn D.
Dabaja, Bouthaina S.
Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
title Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
title_full Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
title_fullStr Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
title_full_unstemmed Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
title_short Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
title_sort multi-institutional investigation: circulating cd4:cd8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662194/
https://www.ncbi.nlm.nih.gov/pubmed/30773193
http://dx.doi.org/10.1016/j.radonc.2018.12.003
work_keys_str_mv AT anyi multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT jiangwen multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT andraostheresey multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT reddyjayp multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT yehiazeinababou multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT lloydshane multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT duvicmadeleine multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT dsouzaneilm multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT milgromsaraha multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT pinnixchelseac multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT okiyasuhiro multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT smithgracel multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT wilsonlynnd multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides
AT dabajabouthainas multiinstitutionalinvestigationcirculatingcd4cd8ratioisaprognosticatorofresponsetototalskinelectronbeamradiationinmycosisfungoides